Which has the lower trailing P/E, WST or ZTS?

ZTS has the lower trailing P/E: WST trades at 47.35 and ZTS at 11.71. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, WST or ZTS?

Over the past five years, WST grew revenue faster — WST at a 5.68% CAGR versus ZTS at 5.13%.

Does WST or ZTS pay a bigger dividend?

WST yields 0.26% and ZTS yields 2.85% based on trailing dividends and the latest price.

Is WST or ZTS more profitable?

ZTS runs the higher net margin — WST at 16.98% versus ZTS at 27.49%.

How have WST and ZTS total returns compared?

Over the past 10 years, WST delivered 15.86% and ZTS delivered 4.74% annualized total return. Past performance doesn't predict future results.

West Pharmaceutical Services, Inc. (WST) vs Zoetis Inc. (ZTS)

A side-by-side comparison of West Pharmaceutical Services, Inc. and Zoetis Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

WST

West Pharmaceutical Services, Inc.

$26.06B

$370.29HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

ZTS

Zoetis Inc.

$29.79B

$71.05HealthcareDelayed quote: Sep 25, 2026, 4:02 PM EDT

Total return — WST vs ZTS

growth of $100 · dividends reinvested · last 10y

WST +318.5% (+15.4%/yr)ZTS +58.8% (+4.7%/yr)WST compounded faster over this window

WST ZTS

WST vs ZTS: by the numbers

•ZTS is the larger company ($29.79B vs $26.06B market cap).
•ZTS trades at the lower trailing earnings multiple (11.71 vs 47.35 P/E), one valuation lens rather than an overall verdict.
•ZTS converts more revenue to profit (27.49% vs 16.98% net margin).
•WST grew revenue faster over the past five years (5.68% vs 5.13% CAGR).
•ZTS pays the higher dividend yield (2.85% vs 0.26%).

Metrics side by side

Valuation

Metric	WST	ZTS
P/E ratio	47.35	11.71
Forward P/E	41.30	11.36
P/S ratio	7.83	3.13
P/B ratio	8.71	9.46
EV / EBITDA	29.92	9.38
FCF yield	1.68%	7.94%

Profitability

Metric	WST	ZTS
Gross margin	36.77%	70.87%
Operating margin	20.64%	37.00%
Net margin	16.98%	27.49%
ROE	18.89%	83.10%
ROIC	15.77%	21.63%

Dividends

Metric	WST	ZTS
Dividend yield	0.26%	2.85%
Payout ratio	11.25%	34.43%

Growth (annualized)

Metric	WST	ZTS
Revenue CAGR (5Y)	5.68%	5.13%
EPS CAGR (5Y)	7.85%	11.88%
FCF CAGR (5Y)	8.74%	6.81%
Total return CAGR (5Y)	-5.84%	-17.75%

Frequently asked

Which has the lower trailing P/E, WST or ZTS?: ZTS has the lower trailing P/E: WST trades at 47.35 and ZTS at 11.71. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, WST or ZTS?: Over the past five years, WST grew revenue faster — WST at a 5.68% CAGR versus ZTS at 5.13%.
Does WST or ZTS pay a bigger dividend?: WST yields 0.26% and ZTS yields 2.85% based on trailing dividends and the latest price.
Is WST or ZTS more profitable?: ZTS runs the higher net margin — WST at 16.98% versus ZTS at 27.49%.
How have WST and ZTS total returns compared?: Over the past 10 years, WST delivered 15.86% and ZTS delivered 4.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full WST analysis Full ZTS analysis Interactive comparison tool

Dig into the metrics

West Pharmaceutical Services P/E ratio Zoetis P/E ratio West Pharmaceutical Services dividend yield Zoetis dividend yield West Pharmaceutical Services ROE Zoetis ROE West Pharmaceutical Services operating margin Zoetis operating margin West Pharmaceutical Services revenue growth Zoetis revenue growth West Pharmaceutical Services free cash flow Zoetis free cash flow

West Pharmaceutical Services & Zoetis appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.